Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000152525 | SCV000201714 | uncertain significance | not specified | 2014-04-10 | criteria provided, single submitter | clinical testing | Variant classified as Uncertain Significance - Favor Benign. The Thr500Ile varia nt in TTN has not been previously reported in individuals with cardiomyopathy or in large population studies. Threonine (Thr) at position 500 is not conserved i n mammals or evolutionarily distant species and rat carries an isoleucine (Ile), supporting that this change may be tolerated. Additional computational predicti on tools suggest that the Thr500Ile variant may not impact the protein, though t his information is not predictive enough to rule out pathogenicity. In summary, although these data support that the Thr500Ile variant may be benign, additional studies are needed to fully assess its clinical significance. |
Prevention |
RCV004528880 | SCV004107982 | uncertain significance | TTN-related disorder | 2023-01-11 | criteria provided, single submitter | clinical testing | The TTN c.1499C>T variant is predicted to result in the amino acid substitution p.Thr500Ile. To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |